Clinical trials
Stroke trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 7 |
| 2009 | 6 |
| 2011 | 4 |
| 2013 | 5 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 44 |
| Terminated | 8 |
| Recruiting | 4 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Christian Medical College and Hospital, Ludhiana, India | 8 |
| Novartis Pharmaceuticals | 4 |
| Boehringer Ingelheim | 3 |
| Mahatma Gandhi Institute of Medical Sciences | 3 |
| Pharmazz, Inc. | 3 |
| Bayer | 2 |
| Maharishi Markendeswar University (Deemed to be University) | 2 |
| Neurogen Brain and Spine Institute | 2 |
| Pfizer | 2 |
| Population Health Research Institute | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stroke | 66 |
| Atrial Fibrillation | 13 |
| Myocardial Infarction | 10 |
| Cardiovascular Diseases | 7 |
| Ischemic Stroke | 6 |
| Brain Ischemia | 3 |
| Cerebral Hemorrhage | 3 |
| Embolism | 3 |
| Hyperlipidemias | 3 |
| Ischemic Attack, Transient | 3 |
Trials
Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.